Newsletter registration

Austria.
Where Your Profits Grow Sky High.

Apeiron Biologics gets a EUR 25 million loan from EIB

Apeiron CEO H. Loibner © Apeiron Biologics

The funds are designed to help the company develop new pharmaceutical products for the treatment of cancer, especially rare types affecting children. The financing for Apeiron was made possible by the “European Fund for Strategic Investments” (EFSI).

Apeiron was founded in 2003 by the geneticist Josef Penninger, the scientific director of the Institute for Molecular Biology (IMBA) in Vienna. In May 2017, the European Commission granted market approval for a therapy focusing on immunotherapy of neuroblastoma. The therapy should increase the survival and chances of recovery for the serious cancer neuroblastoma which affects children at an early age. It is a rare cancer, but is responsible for up to 10% of solid tumors in childhood, affecting about 1,200 children in the EU and USA every year.  

Share on Facebook Share on Facebook Share on Twitter Share on Twitter

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • Russian-Austrian Business Council

    23.11.2017, Kazan, Russian Federation

  • Innovation@Austria? Invest in the technology HotSpot Carinthia.

    29.11.2017 / 10:00, Ljubljana, Slovenia

Austria Map

Find the perfect location for your company

Storage and distribution for Eastern Europe is more economical from Vienna than from Prague or Budapest. Because shipping business between the individual reform nations is barely developed, whereas neary every Eastern destination is serviced from Vienna several times a week.

Hewlett Packard Austria

Logo
More testimonials

news from the business location Austria

Viennese researchers: New hope for treatment of aggressive leukaemia

Up until now, the rare and highly aggressive form of blood cancer called T-PLL leukaemia could not be sufficiently treated in the past.

Highly popular: Austrian startup scene improves connections to Asian hotspots

What do Israel, Japan, Singapore, Hong Kong and South Korea have in common? They belong to the target countries of the Global Incubator Networks (GIN). Over the last two years GIN has been promoting investments in and from these hotspots – as a one-stop-shop for investors, startups and incubators.

More news All blog posts